Early diagnostic biomarkers of Lung cancer; a review study
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 330
فایل این مقاله در 17 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_CAJMPSI-1-3_002
تاریخ نمایه سازی: 9 مرداد 1400
چکیده مقاله:
Lung cancer is the main cause of cancer-related death. Typically, lung cancer has been classified in two histologic types; small and non-small cell (NSC), with adenocarcinoma, squamous cell form and large cell type. The availability of predictive biomarkers for the treatment of NSC lung cancer (NSCLC) has been changed in recent decades, especially in the form of adenocarcinoma. Controlling for sensitizing mutations inside the epidermal growth factor receptor (EGFR) for patients with advanced adenocarcinomas is currently needed before the achievement of anti-EGFR inhibitors (such as erlotinib, gefitinib, afatinib or osimertinib). In a patient with no signs of tumor tissue, the EGFR mutational plasma and urine examination may be performed. ALK gene rearrangement research is required to predict crizotinib reaction. Treatment with ceritinib, alectinib or brigatinib also relies on ALK rearrangements. PD-L۱ should be tested with an approved assay to model reactions in patients with advanced adenocarcinoma or squamous cell NSCLCs to the single pembrolizumab agent in their first-line therapy. As miRNAs are a vital biomarker (diagnostic biomarkers), miRNAs also could be used as a dynamic tumor predictor before and during therapy because of their function in carcinogenesis at all stages. Nevertheless, lncRNA sheds fresh insight into our tumor pathway perception. In biomedicine, lncRNA is intensely involved, which can be used for a wide variety of cancers as a clinical diagnostic and prediction predictor.
کلیدواژه ها:
نویسندگان
Mostafa Khafaei
Human Genetics Research Center, Baqiyatallah University of Medical Sciences Tehran, Iran
Ali Miri
Human Genetics Research Center, Baqiyatallah University of Medical Sciences Tehran, Iran
Ebrahim Kiani
Human Genetics Research Center, Baqiyatallah University of Medical Sciences Tehran, Iran
Elham Danesh
Abadan Faculty of Medical Sciences,Abadan,Iran
Mehdi Naderi
Human Genetics Research Center, Baqiyatallah University of Medical Sciences Tehran, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :